文献速递瓣膜外科

经导管主动脉瓣置换术后瓣周漏的危险因素

Risk factors for paravalvular leak after transcatheter aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-09-27

该单中心回顾性研究纳入2009至2016年539例经导管主动脉瓣植入患者,采用可重复方法测量主动脉瓣钙化体积。结果显示装置着陆区钙化体积和使用CoreValve假体与轻度及以上瓣周漏相关,而Sapien3假体和较大的 oversizing 程度与较低发生率相关。

要点

  • 装置着陆区钙化体积每增加100 mm3,轻度及以上瓣周漏风险增加8%。
  • 使用CoreValve假体者轻度及以上瓣周漏风险是SapienXT的4.1倍。
  • 使用Sapien3假体者轻度及以上瓣周漏风险是SapienXT的0.23倍。

核心结论

  • 装置着陆区主动脉钙化体积与经导管主动脉瓣植入术后残余瓣周漏相关。
  • 考虑钙化因素后,球囊扩张式Sapien3假体似乎与较低的瓣周漏发生率相关。

研究设计与样本

  • 单中心回顾性分析2009至2016年接受经导管主动脉瓣植入术患者的术前增强多排CT扫描。
  • 共纳入539例患者,使用4种假体:SapienXT(n=192)、Sapien3(n=206)、CoreValve EvolutR(n=44)、Acurate(n=97)。
  • 计算每个主动脉瓣叶、左心室流出道和装置着陆区的钙化体积。

主要发现

  • 无患者发生重度瓣周漏;轻度至中度瓣周漏总体发生率为15.8%(95%CI 12.8%-19.1%)。
  • 装置着陆区钙化体积中位数为757 mm3,四组假体间无显著差异。
  • 多变量logistic回归显示装置着陆区钙化(P=.00006;每增加100 mm3的OR=1.08,95%CI 1.04-1.13)和使用CoreValve假体(P=.0028;以SapienXT为参照的OR=4.1,95%CI 1.6-10)与轻度及以上瓣周漏相关。
  • oversizing程度(P=.002;OR=0.97,95%CI 0.95-0.99)和使用Sapien3假体(P=.00005;以SapienXT为参照的OR=0.23,95%CI 0.11-0.47)与较低的轻度及以上瓣周漏发生率相关。

临床怎么用

  • 术前CT测量装置着陆区钙化体积有助于评估经导管主动脉瓣植入术后瓣周漏风险。
  • 对于着陆区钙化体积较大的患者,选择Sapien3假体可能降低瓣周漏风险。

局限性

  • 单中心回顾性研究,结果可能受中心经验和患者选择偏倚影响。
  • 仅纳入4种假体,结论外推至其他假体需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method. METHODS: We retrospectively analyzed preoperative contrast-enhanced multidetector computed tomography scans of patients who underwent transcatheter aortic valve implantation in our center between 2009 and 2016. Calcium volume was calculated for each aortic cusp in the aortic valve, left ventricular outflow tract, and device landing zone. RESULTS: Overall, 539 patients were included in the study who had experience with 4 prothesis types (SapienXT [Edwards Lifesciences, Irvine, Calif] [n = 192], Sapien3 [Edwards Lifesciences] [n = 206], CoreValve EvolutR [Medtronic, Minneapolis, Minn] [n = 44], and Acurate [Symetis, Ecublens, Switzerland] [n = 97]). Median calcium volume in the device landing zone was 757 mm3, with no significant differences among the 4 prosthesis groups. None of the patients had severe PVL. The overall incidence of mild-to-moderate PVL was 15.8% (95% confidence interval [CI], 12.8%-19.1%). On multivariate logistic regression, device landing zone calcification (P = .00006; odds ratio for an increase of 100 mm3, 1.08; 95% CI, 1.04-1.13) and use of the CoreValve (P = .0028; odds ratio, 4.1; 95% CI, 1.6-10 with SapienXT as reference) prosthesis were found to be associated with mild or greater PVL. In contrast, degree of oversizing (P = .002; odds ratio, 0.97; 95% CI, 0.95-0.99), and use of Sapien3 (P = .00005; odds ratio, 0.23; 95% CI, 0.11-0.47 with SapienXT as reference) were associated with a lower incidence of mild or greater PVL. CONCLUSIONS: Aortic calcification volume in the device landing zone is associated with residual PVL after transcatheter aortic valve implantation. When taking calcification into account, the balloon-expandable prosthesis Sapien3 seems to be associated with a lower incidence of PVL.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Pollari F, Dell'Aquila AM, Söhn C, et al. Risk factors for paravalvular leak after transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2018. PMID: 30482527. doi:10.1016/j.jtcvs.2018.08.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。